The alteration in one of the other HRR factors led to cells that show features like that of the BRCA1/2 mutation carrier: this status, defined as “BRCAness”, is also related to a greater risk of developing breast and ovarian cancer [8]. This evidence concerns the gene BRCA1 and ovarian carcinoma.